Literature DB >> 21268049

Simultaneous estimation of E- and Z-isomers of guggulsterone in rabbit plasma using liquid chromatography tandem mass spectrometry and its application to pharmacokinetic study.

R S Bhatta1, D Kumar, Y S Chhonker, G K Jain.   

Abstract

A sensitive and selective liquid chromatography/tandem mass spectrometric method was developed for simultaneous determination of E- and Z-guggulsterone isomers (antihyperlipidemic drug) in rabbit plasma. Both the isomers were resolved on a Symmetry-Shield C(18) (5 µm, 4.6 × 150 mm) column, using gradient elution comprising a mobile phase of methanol, 0.5% v/v formic acid and acetonitrile. With dexamethasone as internal standard, plasma samples were extracted by an automated solid-phase extraction method using C(18) cartridges. Detection was performed by electrospray ionization in multiple reaction monitoring (MRM) in positive mode. The calibration curve was linear over the concentration range of 1.56-200 ng/mL (r(2) ≥ 0.998) for both analytes. The intra-day and inter-day accuracy and precision were within -0.96 to 4.12 (%bias) and 2.73 to 8.00 (%RSD) respectively. The analytes were stable after three freeze-thaw cycles. The method was successfully applied to study steriospecific pharmacokinetics of E- and Z-guggulsterone in NZ rabbit.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21268049     DOI: 10.1002/bmc.1574

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  4 in total

1.  A novel high-performance liquid chromatography-electron spray ionization-mass spectrometry method for simultaneous determination of guggulsterones, piperine and gallic acid in Triphala guggulu.

Authors:  Ganesh Muguli; P R Rao Vadaparthi; B Ramesh; Vishakante Gowda; Rangesh Paramesh; Atul N Jadhav; K Suresh Babu
Journal:  Pharmacogn Mag       Date:  2015-05       Impact factor: 1.085

2.  LC-MS/MS assay for the determination of natamycin in rabbit and human plasma: Application to a pharmacokinetics and protein binding study.

Authors:  Yashpal Singh Chhonker; Devendra Kumar; Pankaj Shrivastava; Deepak Kumar; Rajbir Singh; Hardik Chandasana; Rabi Sankar Bhatta
Journal:  J Pharm Anal       Date:  2012-12-12

Review 3.  Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer.

Authors:  Sosmitha Girisa; Dey Parama; Choudhary Harsha; Kishore Banik; Ajaikumar B Kunnumakkara
Journal:  Explor Target Antitumor Ther       Date:  2020-10-30

4.  Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitro.

Authors:  Wen-Ching Wang; Yih-Huei Uen; Ming-Long Chang; Khoot-Peng Cheah; Joe-Sharg Li; Wen-Yu Yu; Kock-Chee Lee; Cheuk-Sing Choy; Chien-Ming Hu
Journal:  BMC Complement Altern Med       Date:  2012-08-27       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.